7 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
12 Jul 23
Interim Consolidated Financial Statements
8:02am
arm (SMR-weighted hazard ratio [HR]: 1.98; 95% confidence interval [CI]: 1.02, 3.69). Achievement of viral suppression (defined as VL <200 c/mL
6-K
EX-99.1
THTX
Theratechnologies Inc.
12 Jul 23
Theratechnologies Reports Second Quarter 2023
8:00am
) in the treatment arm versus the control arm (SMR-weighted hazard ratio [HR]: 1.98; 95% confidence interval [CI]: 1.02, 3.69). Achievement of viral suppression
6-K
EX-99.2
THTX
Theratechnologies Inc.
21 Jul 22
Material Change Report
4:40pm
and owning similar properties in localities where such Loan Party operates. Each Loan Party maintains, if available, fully paid flood hazard insurance … on all fee owned real property that is located in a special flood hazard area and that constitutes Collateral on such terms and in such amounts
40-F
2011 FY
EX-99.56
THTX
Theratechnologies Inc.
13 Jun 11
Annual report (Canada)
12:00am
® (tesamorelin for injection) (HbA1c level 6.5%) relative to placebo was observed [intent-to-treat hazard ratio of 3.3 (CI 1.4, 9.6)]. Therefore … is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard
40FR12B
EX-99.56
THTX
Theratechnologies Inc.
13 Jun 11
Initial registration of securities (Canada)
12:00am
-to-treat hazard ratio of 3.3 (CI 1.4, 9.6)]. Therefore, glucose status should be carefully evaluated prior to initiating EGRIFTA® (tesamorelin for injection … this drug, the patient should be apprised of the potential hazard to the fetus.
Because of both the potential for HIV-1 infection transmission and serious
40FR12B
EX-99.37
v48wb1rh1wl
13 Jun 11
Initial registration of securities (Canada)
12:00am
40-F
EX-99.37
l2m3zkdw0j84edg60nf2
13 Jun 11
Annual report (Canada)
12:00am
- Prev
- 1
- Next